Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Society Calls For Clarification Of Responsible Pharmacist Regulations
The Royal Pharmaceutical Society has called for clarification of the responsible pharmacist requirements but will not be asking the Department of Health to amend the commencement date of the regulations.

Study Shows US Seniors 'Smarter' Than English Seniors
Researchers from the Peninsula Medical School, the University of Cambridge and the University of Michigan have carried out the first international comparison of cognitive function in nationally representative samples of older adults in the US and England and discovered that US seniors performed significantly better that their English counterparts.
News of the day
Clue To Normal-Tension Glaucoma; Herpes Infection And Corneal Transplants
The July issue of Ophthalmology, the journal of the American Academy of Ophthalmology, includes two studies that may influence clinical treatment of serious eye conditions. One study reports on silent cerebral infarcts (SCI) incidence and visual field loss in patients with normal-tension glaucoma; the other correlates inflammation biomarkers with corneal transplant rejection in herpes simplex patients.
Public Health

OncoGenex Pharmaceuticals To Webcast ASCO Reception On May 30, 2009

OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company will hold a live webcast and conference call of presentations made at an OncoGenex hosted reception during the 2009 American Society of Clinical Oncology Annual Meeting (ASCO) on Saturday, May 30, 2009. The webcast will begin at 7:10 p.m. EDT. During the reception, OncoGenex management and guest speakers will provide a comprehensive review of the final results of a randomized Phase 2 trial presented during an oral presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting, as well as discuss the treatment landscape and the relevance of clinical trial endpoints for prostate cancer. Guest speakers include: - Dr. Kim Chi, OGX-011 Principal Investigator, BC Cancer Agency - Dr. Oliver Sartor, Medical Oncologist, Tulane Medical School - Dr. Tomasz Beer, Medical Oncologist, Oregon Health & Science University - Dr. Brent Blumenstein, Independent Statistician, Trial Architecture Consulting - Dr. Martin Gleave, Distinguished Professor, Department of Urologic Sciences, University of British Columbia and Chief Scientific Officer, OncoGenex Pharmaceuticals, Inc. To access the webcast, log on to the Investor Relations page of the OncoGenex Web site at http://www.oncogenex.com. Alternatively, you may access the live conference call by dialing 877-627-6544 (U.S. & Canada) or 719-325-4857 (International). A webcast replay will be available approximately two hours after the call and will be archived at http://www.oncogenex.com. OncoGenex Pharmaceuticals


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009